Search Results

• • 15 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Future Oncology: a 10-year anniversary issue

  Authors:Nicholas J Ward and Gemma WestcottFrom:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 20151,850 words Editorial 1660LAuthor(s): Nicholas J Ward [*] aff1 , Gemma Westcott aff1 KEYWORDS biomarkers; diagnostics; genomic medicine; oncology; treatment In the 10 years since our launch, the diverse field of oncology has changed...

• Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches

  Authors:Clelia Madeddu, Giovanni Mantovani, Giulia Gramignano, Giorgio Astara, and Antonio MaccioFrom:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 201510,131 words Report 2160LAuthor(s): Clelia Madeddu aff1 , Giovanni Mantovani [*] aff1 , Giulia Gramignano aff2 , Giorgio Astara aff1 , Antonio Macciò aff3 KEYWORDS advanced cancer; cachexia; IL-6; inflammation; mTOR; muscle wasting;...

• Metastatic gastric cancer in the last two decades: goals achieved and future promises

  Authors:Giuseppe Aprile, Nicola Silvestris, Lorenzo Antonuzzo, and Mario ScartozziFrom:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 20152,373 words Editorial 1720LAuthor(s): Giuseppe Aprile [*] aff1 , Nicola Silvestris aff2 , Lorenzo Antonuzzo aff3 , Mario Scartozzi aff4 KEYWORDS angiogenesis; gastric cancer; pembrolizumab; ramucirumab; target therapy; translational...

• Precision medicine in colorectal cancer: evolving genomic landscape and emerging consensus

  Authors:Kurt W Fisher, Antonio Lopez-Beltran, Rodolfo Montironi, and Liang ChengFrom:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 20157,360 words Report 2170LAuthor(s): Kurt W Fisher aff1 , Antonio Lopez-Beltran aff2 aff3 , Rodolfo Montironi aff4 , Liang Cheng [*] aff1 KEYWORDS BRAF ; colorectal cancer; KRAS ; microsatellite instability; molecular diagnostics; NRAS ;...

• Immunotherapy for non-small-cell lung cancer: the past 10 years

  Authors:Johan Vansteenkiste, Julie Craps, Nele De Brucker, and Isabelle WautersFrom:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 201510,228 words Report 1560LAuthor(s): Johan Vansteenkiste [*] aff1 , Julie Craps aff1 , Nele De Brucker aff1 , Isabelle Wauters aff1 KEYWORDS cancer vaccination; checkpoint inhibitors; immunotherapy; non-small-cell lung cancer; receptors,...

• The past, present and future of fertility preservation in cancer patients

  Authors:Charlotte Sonigo, Nathalie Sermondade, Julie Benard, Alexandra Benoit, Joanna Shore, Christophe Sifer, et al.From:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 201511,283 words Report 1860LAuthor(s): Charlotte Sonigo aff1 aff2 aff3 , Nathalie Sermondade aff4 , Julie Benard aff1 aff2 , Alexandra Benoit aff1 , Joanna Shore aff5 , Christophe Sifer aff4 , Michael Grynberg [*] aff1 aff2 aff6 KEYWORDS...

• Breast cancer screening: past, present and future

  Author:Ismail JatoiFrom:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 20152,182 words Editorial 1760LAuthor(s): Ismail Jatoi [*] aff1 KEYWORDS mammography; mortality; overdiagnosis; screening; therapy Ironically, improvements in breast cancer therapy and screening technology are very likely diminishing the...

• Image-guided brachytherapy in cervical cancer: past, present and future

  Authors:Daniel M Trifiletti and Timothy N ShowalterFrom:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 20152,428 words Report 1840LAuthor(s): Daniel M Trifiletti aff1 , Timothy N Showalter [*] aff1 KEYWORDS brachytherapy; cervix; CT; MRI; workflow Background Brachytherapy is an established and critical component of the treatment of...

• Bevacizumab in recurrent glioblastoma: open issues

  Authors:Enrico Franceschi, Marco Bartolotti, and Alba A BrandesFrom:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 20157,709 words Report 1480LAuthor(s): Enrico Franceschi aff1 , Marco Bartolotti aff1 , Alba A Brandes [*] aff1 KEYWORDS anti-angiogenic; bevacizumab; glioblastoma; recurrent Recurrent glioblastoma (GBM) is characterized by a dismal...

• The development of stereotactic body radiotherapy in the past decade: a global perspective

  Authors:Simon S Lo, Ben J Slotman, Michael Lock, Yasushi Nagata, Matthias Guckenberger, Shankar Siva, et al.From:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 201510,976 words Report 1810LAuthor(s): Simon S Lo [*] aff1 , Ben J Slotman aff2 , Michael Lock aff3 , Yasushi Nagata aff4 , Matthias Guckenberger aff5 , Shankar Siva aff6 , Matthew Foote aff7 , Daniel Tan aff8 , Bin S Teh aff9 , Nina A Mayr aff10...

• The expanding role of chemotherapy in prostate cancer

  Authors:Giuseppe Di Lorenzo and Guru SonpavdeFrom:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 20152,623 words Editorial 1820LAuthor(s): Giuseppe Di Lorenzo [*] aff1 , Guru Sonpavde aff2 KEYWORDS castration-resistant stage; chemotherapy; hormone-sensitive stage; hormonal therapy; prostate cancer The past The mainstay of treatment...

• Cancer endocrinology: noticeable developments in the last decade

  Author:Lev M BersteinFrom:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 20152,438 words Editorial 2080LAuthor(s): Lev M Berstein [*] aff1 KEYWORDS cancer; endocrinology; hormone; present and future of oncology The past 10 years have been rich in new developments, potentially leading to important breakthroughs in...

• Steps ahead in the treatment of advanced colorectal cancer: past, current and possible future scenarios

  Authors:Giuseppe Aprile, Karim Rihawi, Mario Scartozzi, and Roberto BordonaroFrom:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 20152,446 words Editorial 1810LAuthor(s): Giuseppe Aprile [*] aff1 , Karim Rihawi aff1 , Mario Scartozzi aff2 , Roberto Bordonaro aff3 KEYWORDS antiangiogenics; clinical research; colorectal cancer; EGFR inhibitors; translational research...

• Rare tumors: an eye on the future

  Authors:Mandeep S Sagoo, Aleksandra Filipovic, Lamis Al Harby, and Justin StebbingFrom:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 20152,701 words Report 1740LAuthor(s): Mandeep S Sagoo aff1 aff2 aff3 , Aleksandra Filipovic aff4 , Lamis Al Harby aff1 aff2 , Justin Stebbing [*] aff4 KEYWORDS rare tumors; retinoblastoma; uveal melanoma Cancers of the eye are rare, but...

• Cytotoxic effects of chemotherapy on cancer and immune cells: how can it be modulated to generate novel therapeutic strategies?

  Authors:Cedric Rebe and Francois GhiringhelliFrom:Future Oncology (Vol. 11, Issue 19) Peer-Reviewed

  Oct. 20156,659 words Report 1900LAuthor(s): Cédric Rébé [*] aff1 aff2 , François Ghiringhelli aff1 aff2 aff3 KEYWORDS cancer; chemotherapy; immune cells Chemotherapy was first studied for the efficacy of its principal intention, that is, to...